AML, ADULT
Clinical trials for AML, ADULT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT trials appear
Sign up with your email to follow new studies for AML, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World data could unlock access to promising AML drug in europe
Disease control Recruiting nowThis study looks back at the medical records of 250 adults with a specific genetic subtype of acute myeloid leukemia (AML) who received the drug Ivosidenib through a special access program in France. The goal is to see how well the drug works and how safe it is in everyday medica…
Matched conditions: AML, ADULT
Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 26, 2026 06:20 UTC
-
New hope for AML patients: targeted drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib added to standard chemotherapy and a targeted therapy (midostaurin) for people with a specific genetic type of acute myeloid leukemia (AML). The goal is to find a safe dose and see how well it works to put the cancer into r…
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
New hope for older leukemia patients: which chemo works best?
Disease control Recruiting nowThis study tests two different chemotherapy combinations in adults aged 55 to 75 with acute myeloid leukemia (AML) who are healthy enough for strong treatment. One group gets a newer drug combo (venetoclax plus azacitidine), while the other gets standard chemotherapy. The goal is…
Matched conditions: AML, ADULT
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New hope for tough leukemia? early trial of eganelisib begins
Disease control Recruiting nowThis early-phase study tests a new drug called eganelisib, given alone or with standard chemotherapy (cytarabine), in about 125 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has returned or not responded to prior treatment. The main goals a…
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New study aims to cut unnecessary blood transfusions in End-Stage blood cancer patients
Symptom relief Recruiting nowThis study looks at adults with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who are receiving palliative care. Instead of giving blood transfusions based only on a fixed hemoglobin level, researchers will use a quality-of-life questionnaire to decide …
Matched conditions: AML, ADULT
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated May 26, 2026 06:20 UTC